Cycrimine

Cycrimine
Clinical data
License data
ATC code none
Identifiers
CAS Number 77-39-4
PubChem (CID) 2911
DrugBank DB00942
ChemSpider 2808
UNII 543567RFQQ YesY
ChEBI CHEBI:59692 YesY
ChEMBL CHEMBL1201227
ECHA InfoCard 100.000.932
Chemical and physical data
Formula C19H29NO
Molar mass 287.4 g/mol
3D model (Jmol) Interactive image

Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]

Synthesis

Cycrimine synthesis:[2]

See also

References

  1. Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, page 218
  2. Denton, J. J.; Schedl, H. P.; Lawson, Virginia A.; Neier, W. B. (1950). "Antispasmodics. VII.1 Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.